Author/Creator: Barta, Pavel - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Barta, Pavel

1. In vitro evaluation of concentration, labeling effectiveness and stability for 131I‐labeled radioimmunoassay ligand using real‐time detection technology. (13th December 2016)

Authors:: Barta, Pavel; Janousek, Jiri; Zilkova, Katerina; Trejtnar, Frantisek
Journal:: Journal of labelled compounds & radiopharmaceuticals
Issue:: Volume 60:Number 1(2017)
Page Start:: 80
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging. (14th April 2021)

Authors:: Novy, Zbynek; Janousek, Jiri; Barta, Pavel; Petrik, Milos; Hajduch, Marian; Trejtnar, Frantisek
Journal:: Journal of labelled compounds & radiopharmaceuticals
Issue:: Volume 64:Number 7(2021)
Page Start:: 262
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor. (30th January 2013)

Authors:: Barta, Pavel; Laznickova, Alice; Laznicek, Milan; Vera, Denis Rolando Beckford; Beran, Milos
Journal:: Journal of labelled compounds & radiopharmaceuticals
Issue:: Volume 56:Number 5(2013)
Page Start:: 280
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The effect of chelator type on in vitro receptor binding and stability in 177Lu‐labeled cetuximab and panitumumab. (29th May 2014)

Authors:: Novy, Zbynek; Laznickova, Alice; Mandikova, Jana; Barta, Pavel; Laznicek, Milan; Trejtnar, Frantisek
Journal:: Journal of labelled compounds & radiopharmaceuticals
Issue:: Volume 57:Number 7(2014)
Page Start:: 448
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors. (January 2019)

Authors:: Hyrsova, Lucie; Vanduchova, Alena; Dusek, Jan; Smutny, Tomas; Carazo, Alejandro; Maresova, Veronika; Trejtnar, Frantisek; Barta, Pavel; Anzenbacher, Pavel; Dvorak, Zdenek; Pavek, Petr
Journal:: Toxicology letters
Issue:: Volume 300(2019)
Page Start:: 81
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗